Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 2000 Feb;82(2):126–130. doi: 10.1136/adc.82.2.126

Randomised placebo controlled trial of nebulised corticosteroids in acute respiratory syncytial viral bronchiolitis

A Cade 1, K Brownlee 1, S Conway 1, D Haigh 1, A Short 1, J Brown 1, D Dassu 1, S Mason 1, A Phillips 1, R Eglin 1, M Graham 1, A Chetcuti 1, M Chatrath 1, N Hudson 1, A Thomas 1, P Chetcuti 1
PMCID: PMC1718208  PMID: 10648365

Abstract

OBJECTIVE—To evaluate short and long term effects of giving nebulised budesonide early in respiratory syncytial viral (RSV) bronchiolitis.
DESIGN—A multicentre randomised double blind placebo controlled trial.
SUBJECTS—Infants admitted to hospital with their first episode of RSV positive bronchiolitis.
INTERVENTION—Randomisation to receive either 1 mg of nebulised budesonide (Bud) or placebo (Pla) twice daily from admission until 2 weeks after discharge. Follow up was for 12months.
MAIN OUTCOME MEASURES—Duration of hospital admission, time taken to become symptom free, re-admission rates, general practitioner consultation rates, and use of antiwheeze medication during follow up.
RESULTS—161 infants were studied. Both arms were similar with respect to initial clinical severity, age, sex, socioeconomic class, and tobacco exposure. Median time from first nebulisation to discharge: Bud and Pla, 2 days. Median number of days for 50% of infants to be symptom free for 48 hours: Bud, 10 days; Pla, 12 days. Respiratory re-admission rates in the 12 month follow up: Bud, 16%; Pla, 18%; median difference (95% confidence interval (CI)), −2 (−14 to 10). Median respiratory related general practitioner attendances: Bud, 4.0; Pla, 4.5; median difference (95% CI), −1 (−2 to 0). Percentage of infants receiving at least one prescription for antiwheeze medication during follow up, corticosteroids: Bud, 50%; Pla, 60%; difference (95% CI), −10 (−26 to 6); bronchodilators: Bud, 60%; Pla, 67%; difference (95% CI), −7 (−22 to 8).
CONCLUSIONS—There are no short or long term clinical benefits from the administration of nebulised corticosteroids in the acute phase of RSV bronchiolitis.



Full Text

The Full Text of this article is available as a PDF (121.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carlsen K. H., Leegaard J., Larsen S., Orstavik I. Nebulised beclomethasone dipropionate in recurrent obstructive episodes after acute bronchiolitis. Arch Dis Child. 1988 Dec;63(12):1428–1433. doi: 10.1136/adc.63.12.1428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Dabbous I. A., Tkachyk J. S., Stamm S. J. A double blind study on the effects of corticosteroids in the treatment of bronchiolitis. Pediatrics. 1966 Mar;37(3):477–484. [PubMed] [Google Scholar]
  3. Daugbjerg P., Brenøe E., Forchhammer H., Frederiksen B., Glazowski M. J., Ibsen K. K., Knabe N., Leth H., Marner B., Pedersen F. K. A comparison between nebulized terbutaline, nebulized corticosteroid and systemic corticosteroid for acute wheezing in children up to 18 months of age. Acta Paediatr. 1993 Jun-Jul;82(6-7):547–551. doi: 10.1111/j.1651-2227.1993.tb12750.x. [DOI] [PubMed] [Google Scholar]
  4. Everard M. L., Swarbrick A., Wrightham M., McIntyre J., Dunkley C., James P. D., Sewell H. F., Milner A. D. Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. Arch Dis Child. 1994 Nov;71(5):428–432. doi: 10.1136/adc.71.5.428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Klassen T. P., Sutcliffe T., Watters L. K., Wells G. A., Allen U. D., Li M. M. Dexamethasone in salbutamol-treated inpatients with acute bronchiolitis: a randomized, controlled trial. J Pediatr. 1997 Feb;130(2):191–196. doi: 10.1016/s0022-3476(97)70342-1. [DOI] [PubMed] [Google Scholar]
  6. Kuikka L., Reijonen T., Remes K., Korppi M. Bronchial asthma after early childhood wheezing: a follow-up until 4.5-6 years of age. Acta Paediatr. 1994 Jul;83(7):744–748. doi: 10.1111/j.1651-2227.1994.tb13131.x. [DOI] [PubMed] [Google Scholar]
  7. Leer J. A., Jr, Green J. L., Heimlich E. M., Hyde J. S., Moffet H. L., Young G. A., Barron B. A. Corticosteroid treatment in bronchiolitis. A controlled, collaborative study in 297 infants and children. Am J Dis Child. 1969 May;117(5):495–503. [PubMed] [Google Scholar]
  8. Lødrup Carlsen K. C., Nikander K., Carlsen K. H. How much nebulised budesonide reaches infants and toddlers? Arch Dis Child. 1992 Sep;67(9):1077–1079. doi: 10.1136/adc.67.9.1077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Martinez F. D., Morgan W. J., Wright A. L., Holberg C., Taussig L. M. Initial airway function is a risk factor for recurrent wheezing respiratory illnesses during the first three years of life. Group Health Medical Associates. Am Rev Respir Dis. 1991 Feb;143(2):312–316. doi: 10.1164/ajrccm/143.2.312. [DOI] [PubMed] [Google Scholar]
  10. Murray M., Webb M. S., O'Callaghan C., Swarbrick A. S., Milner A. D. Respiratory status and allergy after bronchiolitis. Arch Dis Child. 1992 Apr;67(4):482–487. doi: 10.1136/adc.67.4.482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Nahata M. C., Schad P. A. Pattern of drug usage in bronchiolitis. J Clin Pharm Ther. 1994 Apr;19(2):117–118. doi: 10.1111/j.1365-2710.1994.tb01122.x. [DOI] [PubMed] [Google Scholar]
  12. Pullan C. R., Hey E. N. Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy. Br Med J (Clin Res Ed) 1982 Jun 5;284(6330):1665–1669. doi: 10.1136/bmj.284.6330.1665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Reijonen T., Korppi M., Kuikka L., Remes K. Anti-inflammatory therapy reduces wheezing after bronchiolitis. Arch Pediatr Adolesc Med. 1996 May;150(5):512–517. doi: 10.1001/archpedi.1996.02170300066013. [DOI] [PubMed] [Google Scholar]
  14. Richter H., Seddon P. Early nebulized budesonide in the treatment of bronchiolitis and the prevention of postbronchiolitic wheezing. J Pediatr. 1998 May;132(5):849–853. doi: 10.1016/s0022-3476(98)70316-6. [DOI] [PubMed] [Google Scholar]
  15. Rooney J. C., Williams H. E. The relationship between proved viral bronchiolitis and subsequent wheezing. J Pediatr. 1971 Nov;79(5):744–747. doi: 10.1016/s0022-3476(71)80385-2. [DOI] [PubMed] [Google Scholar]
  16. Roosevelt G., Sheehan K., Grupp-Phelan J., Tanz R. R., Listernick R. Dexamethasone in bronchiolitis: a randomised controlled trial. Lancet. 1996 Aug 3;348(9023):292–295. doi: 10.1016/s0140-6736(96)02285-4. [DOI] [PubMed] [Google Scholar]
  17. Sammartino L., Rasiah S., Wale L., Lines D. Budesonide in acute bronchiolitis. J Paediatr Child Health. 1995 Feb;31(1):61–62. [PubMed] [Google Scholar]
  18. Sigurs N., Bjarnason R., Sigurbergsson F., Kjellman B., Björkstén B. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics. 1995 Apr;95(4):500–505. [PubMed] [Google Scholar]
  19. Sims D. G., Downham M. A., Gardner P. S., Webb J. K., Weightman D. Study of 8-year-old children with a history of respiratory syncytial virus bronchiolitis in infancy. Br Med J. 1978 Jan 7;1(6104):11–14. doi: 10.1136/bmj.1.6104.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Springer C., Bar-Yishay E., Uwayyed K., Avital A., Vilozni D., Godfrey S. Corticosteroids do not affect the clinical or physiological status of infants with bronchiolitis. Pediatr Pulmonol. 1990;9(3):181–185. doi: 10.1002/ppul.1950090311. [DOI] [PubMed] [Google Scholar]
  21. Stokes G. M., Milner A. D., Hodges I. G., Groggins R. C. Lung function abnormalities after acute bronchiolitis. J Pediatr. 1981 Jun;98(6):871–874. doi: 10.1016/s0022-3476(81)80577-x. [DOI] [PubMed] [Google Scholar]
  22. Young S., O'Keeffe P. T., Arnott J., Landau L. I. Lung function, airway responsiveness, and respiratory symptoms before and after bronchiolitis. Arch Dis Child. 1995 Jan;72(1):16–24. doi: 10.1136/adc.72.1.16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. van Woensel J. B., Wolfs T. F., van Aalderen W. M., Brand P. L., Kimpen J. L. Randomised double blind placebo controlled trial of prednisolone in children admitted to hospital with respiratory syncytial virus bronchiolitis. Thorax. 1997 Jul;52(7):634–637. doi: 10.1136/thx.52.7.634. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES